The effect of a nurse-led prednisolone tapering regimen in polymyalgia rheumatica: a retrospective cohort study

C Mørk, MY Dam, MG Callsen, KK Keller - Rheumatology International, 2021 - Springer
The objective of this study is to investigate the efficacy of a nurse-led prednisolone tapering
regime in patients with polymyalgia rheumatica (PMR) compared to standard care. It is a …

FRI0253 Clinical Efficacy of Tocilizumab in Polymyalgia Rheumatica: An Open-Label Study

E Toussirot, A Martin, M Soubrier, S Redeker, A Regent - 2015 - ard.bmj.com
Background Polymyalgia rheumatic (PMR) is a chronic inflammatory disorder of unknown
etiology that affects elderly people. Corticosteroids (CS) are still the mainstay of therapy for …

Impact of age at diagnosis in polymyalgia rheumatica: a retrospective cohort study of 218 patients

M Van Hemelen, A Betrains, S Vanderschueren… - Autoimmunity …, 2020 - Elsevier
Background Polymyalgia rheumatica (PMR) is a common musculoskeletal inflammatory
disease that may occur with giant-cell arteritis (GCA) or in an isolated form. While the …

POS1460-HPR PREVALENCE AND MANAGEMENT OF PATIENTS WITH COMORBIDITIES AND FRAILTY IN NEW ONSET POLYMYALGIA RHEUMATICA

SE Sattui, F Buttgereit, M Lidar, K Ford, S Fiore… - 2024 - ard.bmj.com
Background: Polymyalgia rheumatica (PMR), a common inflammatory rheumatic disease in
older adults, is primarily treated with glucocorticoids (GC). A high comorbidity burden in …

Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial

C Salvarani, PL Macchioni, C Manzini… - Annals of Internal …, 2007 - acpjournals.org
Background: A reliable alternative to steroids for treating polymyalgia rheumatica has not yet
been identified. Although infliximab has been used occasionally in steroid-resistant cases …

Recent advances in the diagnosis and treatment of polymyalgia rheumatica

F Muratore, G Pazzola, N Pipitone… - Expert Review of …, 2016 - Taylor & Francis
Introduction: Polymyalgia rheumatica is one of the most common rheumatic inflammatory
disorders in people older than 50 years characterized by aching and prolonged morning …

Tocilizumab in isolated polymyalgia rheumatica: a systematic literature review

M Akiyama, Y Kaneko, T Takeuchi - Seminars in Arthritis and Rheumatism, 2020 - Elsevier
Objective We investigated the effectiveness of tocilizumab (an anti-interleukin-6 receptor
antibody) in patients with polymyalgia rheumatica (PMR). Methods We performed a …

Polymyalgia rheumatica: inflammation suppression with low dose of methylprednisolone or modified-release prednisone

M Benucci, B Olivito, M Manfredi, F Meacci… - European Review for …, 2015 - air.unimi.it
OBJECTIVE: Polymyalgia rheumatica (PMR) is an inflammatory disease that affects people
aged> 50 years, and is characterised by pain and morning stiffness in the shoulder and …

POS1429 IMMUNE CHECKPOINT INHIBITOR-MEDIATED POLYMYALGIA RHEUMATICA VERSUS PRIMARY POLYMYALGIA RHEUMATICA: COMPARISON OF …

K Van der Geest, O Vermeulen, E Brouwer, R Slart… - 2024 - ard.bmj.com
Background: The introduction of immune checkpoint inhibitors (ICI) has been a significant
breakthrough in the field of oncology. However, removal of the brake on the immune system …

Longitudinal clusters of pain and stiffness in polymyalgia rheumatica: 2-year results from the PMR Cohort Study

S Muller, R Whittle, SL Hider, J Belcher… - …, 2020 - academic.oup.com
Objectives To investigate potential subgroups of primary care–diagnosed patients with PMR
based on self-reported pain and stiffness severity over time. Methods A total of 652 people …